Another example could be The Aza-BFcell-106 vaccine, which couples Aza-stimulated melanoma cells with a TLR7 agonist and showed enhanced immunogenicity and therapeutic potential in melanoma (145). The gene discussed is TLR7; the disease is melanoma.